Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Immune Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04424602
What this trial is testing

Comparison between2 Drugs in Lupus Nephritis

Who this might be right for
Lupus Nephritis
Al-Azhar University 40
Post-approval studies (Phase 4)Study completedNCT00668330
What this trial is testing

Steroid Induced Osteoporosis in Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Chinese University of Hong Kong 40
Not applicableStudy completedNCT00010400
What this trial is testing

Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome

Who this might be right for
Systemic Lupus ErythematosusAntiphospholipid Antibody Syndrome
Johns Hopkins University 35
Not applicableLooking for participantsNCT06631404
What this trial is testing

Renal Arterial Resistive Index as a Noninvasive Biomarker of Disease Activity in Lupus Nephritis Patients

Who this might be right for
Lupus Nephritis
Sohag University 55
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07687004
What this trial is testing

Sonrotoclax and BCMA Bispecific Antibody in Newly Diagnosed Systemic AL Amyloidosis Based on t(11;14) Genetic Stratification

Who this might be right for
Multiple Myeloma (MM)
Institute of Hematology & Blood Diseases Hospital, China 50
Not applicableLooking for participantsNCT01802034
What this trial is testing

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

Who this might be right for
Kidney DiseasesKidney Failure, ChronicDiabetic Nephropathy+2 more
The Rogosin Institute 2,000
Not applicableLooking for participantsNCT06627309
What this trial is testing

Rapid dFLC Response Predict CHR in AL Amyloidosis

Who this might be right for
Systemic AL Amyloidosis
Peking University People's Hospital 50
Post-approval studies (Phase 4)Looking for participantsNCT07101445
What this trial is testing

Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

Who this might be right for
Multiple Myeloma
Emory University 94
Not applicableStudy completedNCT03780712
What this trial is testing

Immune Dysfunction in Newborn Sepsis

Who this might be right for
Sepsis NewbornMalariaImmune Responses
BioMérieux 585
Testing effectiveness (Phase 2)Study completedNCT02953301
What this trial is testing

Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS)

Who this might be right for
Mycosis FungoidesSezary SyndromeLymphoma, T-Cell, Cutaneous
4SC AG 201
Early research (Phase 1)Looking for participantsNCT07432334
What this trial is testing

CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus

Who this might be right for
Refractory Systemic Lupus Erythematosus
Vinmec Research Institute of Stem Cell and Gene Technology 8
Early research (Phase 1)Looking for participantsNCT06576271
What this trial is testing

GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 142
Large-scale testing (Phase 3)Looking for participantsNCT05609630
What this trial is testing

Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.

Who this might be right for
Juvenile Idiopathic Arthritis
AbbVie 90
Early research (Phase 1)Ended earlyNCT00122564
What this trial is testing

Study of HIV-1 Rgp-160 Administered by Mucosal Routes in Healthy Volunteers

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 36
Early research (Phase 1)Study completedNCT04318600
What this trial is testing

Allogeneic Amniotic Mesenchymal Stem Cell Therapy for Lupus Nephritis

Who this might be right for
Lupus NephritisMesenchymal Stem Cells
Yan'an Affiliated Hospital of Kunming Medical University 16
Not applicableStudy completedNCT05289544
What this trial is testing

Phone-Based Based Walk With Ease Program for Adults With Arthritis

Who this might be right for
ArthritisGoutFibromyalgia+3 more
University of South Carolina 267
Large-scale testing (Phase 3)Active Not RecruitingNCT04895241
What this trial is testing

Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Biogen 548
Not applicableStudy completedNCT00197691
What this trial is testing

Botswana Pediatric Respiratory Disease and Bloodstream Infection Study

Who this might be right for
HIV InfectionsRespiratory Tract DiseasesSepsis
Harvard School of Public Health (HSPH)
Not applicableUnknownNCT03143413
What this trial is testing

Echo Systemic Sclerosis

Who this might be right for
Systemic SclerosisGougerot Sjogren SyndromeSicca-Asthenia-Polyalgia Syndrome
University Hospital, Clermont-Ferrand 100
Testing effectiveness (Phase 2)Looking for participantsNCT06292780
What this trial is testing

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

Who this might be right for
Relapsed/Refractory Systemic Light Chain Amyloidosis
Regeneron Pharmaceuticals 220
Next Page